Literature DB >> 19093187

Muir-Torre syndrome associated with endometrial carcinoma.

Toshimitsu Tohya1, Takeshi Ogura, Kengo Nishi, Hazuki Nishi, Kazumi Kuriwaki.   

Abstract

Muir-Torre syndrome (MTS) is an autosomaldominant skin condition of genetic origin, characterized by tumors of the sebaceous glands or keratoacanthomas that are associated with malignant visceral diseases. MTS associated with gynecologic malignancy has rarely been reported. Here we report a woman with no family history of colorectal cancer who developed endometrial carcinoma, stage 3a, at 49 years of age and at age 51 years, developed two skin tumors, a nasal squamous cell carcinoma and a sebaceous carcinoma of the right eyelid. The appearance pattern of these skin tumors suggested MTS. Although MTS associated with endometrial carcinoma is rare, patients with endometrial carcinoma should undergo evaluation for visceral malignancies (mainly colon cancer) and sebaceous skin lesions, regardless of whether or not there is a family history of colorectal cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19093187     DOI: 10.1007/s10147-008-0783-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  8 in total

Review 1.  Muir-Torre syndrome.

Authors:  Giovanni Ponti; Maurizio Ponz de Leon
Journal:  Lancet Oncol       Date:  2005-12       Impact factor: 41.316

2.  Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice.

Authors:  Annika Vogt; Jennifer Hebert; Jimmy Hwang; Ying Lu; Ervin H Epstein
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

3.  A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene.

Authors:  M Vernez; P Hutter; C Monnerat; N Halkic; O Gugerli; H Bouzourene
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

4.  Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.

Authors:  Giovanni Ponti; Lorena Losi; Carmela Di Gregorio; Luca Roncucci; Monica Pedroni; Alessandra Scarselli; Piero Benatti; Stefania Seidenari; Giovanni Pellacani; Luigi Lembo; Giuseppina Rossi; Massimiliano Marino; Emanuela Lucci-Cordisco; Maurizio Ponz de Leon
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

5.  Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.

Authors:  Micaela Mathiak; Arno Rütten; Elisabeth Mangold; Hans-Peter Fischer; Thomas Ruzicka; Waltraut Friedl; Peter Propping; Roland Kruse
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

6.  Muir-Torre syndrome: a case of this uncommon entity.

Authors:  Andrew Weinstein; Keyvan Nouri; Shirley Bassiri-Tehrani; Francisco Flores; Gloria Jimenez
Journal:  Int J Dermatol       Date:  2006-03       Impact factor: 2.736

7.  Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.

Authors:  Pilar Machin; Lluis Catasus; Cristina Pons; Josefina Muñoz; Jose Maria Conde-Zurita; Judith Balmaña; Maria Barnadas; Rosa M Martí; Jaime Prat; Xavier Matias-Guiu
Journal:  J Cutan Pathol       Date:  2002-08       Impact factor: 1.587

8.  Sebaceous gland adenoma of the palpebral conjunctiva in a patient with Muir-Torre-syndrome: a case report.

Authors:  F Meier-Gibbons; E Messmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-12       Impact factor: 3.117

  8 in total
  2 in total

Review 1.  Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?

Authors:  Adele Wong; Joanne Ngeow
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

Review 2.  Muir-Torre Syndrome Associated Periocular Sebaceous Neoplasms: Screening Patterns in the Literature and in Clinical Practice.

Authors:  Maya Eiger-Moscovich; Ralph C Eagle; Carol L Shields; Hilary Racher; Sara E Lally; Rona Z Silkiss; Jerry A Shields; Tatyana Milman
Journal:  Ocul Oncol Pathol       Date:  2020-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.